U.S. patent application number 10/645310 was filed with the patent office on 2005-02-24 for dual layer tablet, method of making and use thereof.
Invention is credited to Clark, Michael B., Lachocki, Thomas M., Lan, Tian, Purdy, David F..
Application Number | 20050040116 10/645310 |
Document ID | / |
Family ID | 34194304 |
Filed Date | 2005-02-24 |
United States Patent
Application |
20050040116 |
Kind Code |
A1 |
Purdy, David F. ; et
al. |
February 24, 2005 |
DUAL LAYER TABLET, METHOD OF MAKING AND USE THEREOF
Abstract
A method for treating a recirculating water system which
comprises introducing into said water system a multifunctional,
multilayer tablet, wherein the multilayer tablet comprises a fast
dissolving layer and a slow dissolving layer, wherein said fast
dissolving layer releases a combination of active ingredients
including a member selected from the group consisting of lithium
hypochlorite, calcium hypochlorite, trichloroisocyanuric acid
(TCCA), anhydrous sodium dichloroisocyanurate, sodium persulfate,
potassium persulfate, potassium monopersulfate, sodium
monopersulfate, and mixtures thereof, and at least one of a
clarifier, chelating agent, sequesterant, algaestat, water
softener, algaecide, corrosion inhibitor, scale inhibitor,
flocculent, disintegrant, dispersant, colorant, dissolution control
agent, fragrance, or surfactant and, wherein said slow dissolving
layer includes a member selected from the group consisting of
trichloroisocyanuric acid (TCCA), calcium hypochlorite,
1,3-dichloro-5,5-dimethylhydantoin (DCDMH),
1,3-dibromo-5,5-dimethylhydantoin (DBDMH),
1-bromo-3-chloro-5,5-dimethylh- ydantoin (BCDMH),
1,3-dichloro-5-ethyl-5-methylhydantoin (DCEMH),
1,3-dibromo-5-ethyl-5-methylhydantoin (DBEMH),
1-bromo-3-chloro-5-methyl-- 5-ethylhydantoin (BCEMH), and mixtures
thereof, and at least one of a clarifier, chelating agent,
sequesterant, algaestat, water softener, algaecide, corrosion
inhibitor, scale inhibitor, flocculent, disintegrant, dispersant,
colorant, dissolution control agent or surfactant.
Inventors: |
Purdy, David F.; (Decatur,
GA) ; Lan, Tian; (Marietta, GA) ; Clark,
Michael B.; (Alpharetta, GA) ; Lachocki, Thomas
M.; (Duluth, GA) |
Correspondence
Address: |
SMITH, GAMBRELL & RUSSELL, LLP
SUITE 3100, PROMENADE II
1230 PEACHTREE STREET, N.E.
ATLANTA
GA
30309-3592
US
|
Family ID: |
34194304 |
Appl. No.: |
10/645310 |
Filed: |
August 21, 2003 |
Current U.S.
Class: |
210/749 |
Current CPC
Class: |
C02F 2303/04 20130101;
C02F 1/76 20130101; C02F 1/688 20130101 |
Class at
Publication: |
210/749 |
International
Class: |
C02F 001/68 |
Claims
We claim:
1. A method for treating a recirculating water system which
comprises introducing into said water system a multifunctional,
multilayer tablet, wherein the multilayer tablet comprises a fast
dissolving layer and a slow dissolving layer, wherein said fast
dissolving layer releases a combination of active ingredients
including a member selected from the group consisting of lithium
hypochlorite, calcium hypochlorite, trichloroisocyanuric acid
(TCCA), anhydrous sodium dichloroisocyanurate, sodium persulfate,
potassium persulfate, potassium monopersulfate, sodium
monopersulfate, and mixtures thereof, and at least one of a
clarifier, chelating agent, sequesterant, algaestat, water
softener, algaecide, corrosion inhibitor, scale inhibitor,
flocculent, disintegrant, dispersant, colorant, dissolution control
agent, fragrance, or surfactant and, wherein said slow dissolving
layer includes a member selected from the group consisting of
trichloroisocyanuric acid (TCCA), calcium hypochlorite,
1,3-dichloro-5,5-dimethylhydantoin (DCDMH),
1,3-dibromo-5,5-dimethylhydantoin (DBDMH),
1-bromo-3-chloro-5,5-dimethylh- ydantoin (BCDMH),
1,3-dichloro-5-ethyl-5-methylhydantoin (DCEMH),
1,3-dibromo-5-ethyl-5-methylhydantoin (DBEMH),
1-bromo-3-chloro-5-methyl-- 5-ethylhydantoin (BCEMH), and mixtures
thereof, and at least one of a clarifier, chelating agent,
sequesterant, algaestat, water softener, algaecide, corrosion
inhibitor, scale inhibitor, flocculent, disintegrant, dispersant,
colorant, dissolution control agent or surfactant.
2. The method according to claim 1 wherein the fast dissolving
layer is formulated to release the combination of active
ingredients in less than 12 hours.
3. The method according to claim 1 wherein the slow dissolving
layer is formulated to release said component in an extended period
of time that is greater than 1 day.
4. The method according to claim 1 wherein the fast dissolving
layer is formulated to release a combination of active ingredients
in less than 6 hours upon addition to a water system.
5. The method according to claim 1 wherein the slow dissolving
layer is formulated to release the combination of components in a
time period from 2 to 30 days upon addition to the water
system.
6. The method according to claim 1 wherein the fast dissolving
layer is anhydrous sodium dichloroisocyanuric acid and the slow
dissolving layer is trichloroisocyanuric acid.
7. The method according to claim 1 wherein an active halogen
component is present in the slow dissolving layer at a level of
from 50% to 99% by weight.
8. The method according to claim 1 wherein the fast dissolving
layer has a dissolution aid selected from the group consisting of
alkali metal and alkaline earth carbonate salts, sodium cyanurate,
disodium cyanurate and trisodium cyanurate.
9. The method according to claim 1 wherein the fast dissolving
layer further includes sodium or potassium monopersulfate or sodium
or potassium persulfate
10. The method according to claim 1 wherein the tablet contains a
corrosion inhibitor.
11. The method according to claim 1 wherein the tablet contains a
scale inhibitor or water softener.
12. The method according to claim 1 wherein the tablet contains a
water clarifier.
13. The method according to claim 1 wherein the tablet contains an
oxidizer.
14. The method according to claim 1 wherein the tablet contains an
algaecide.
15. The method according to claim 1 wherein the tablet contains a
surfactant and/or dispersant.
16. The method according to claim 1 wherein the tablet contains a
binder.
17. The method according to claim 16 wherein the binder is a member
selected from the group consisting of natural polymers and
synthetic polymers.
18. The method according to claim 1 wherein the tablet contains a
colorant.
19. The method according to claim 1 wherein the tablet contains a
fragrance.
20. A multilayer tablet which comprises a fast dissolving layer and
a slow dissolving layer wherein the fast dissolving layer contains
a member selected from the group consisting of of lithium
hypochlorite, calcium hypochlorite, trichloroisocyanuric acid
(TCCA), anhydrous sodium dichloroisocyanurate, sodium persulfate,
potassium persulfate, potassium monopersulfate, sodium
monopersulfate, and mixtures thereof, and one or more of a
clarifier, chelating agent, sequesterant, algaestat, water
softener, algaecide, corrosion inhibitor, scale inhibitor,
flocculent, disintegrant, dispersant, colorant, dissolution control
agent, fragrance, or surfactant and, wherein said slow dissolving
layer includes a member selected from the group consisting of
trichloroisocyanuric acid (TCCA), calcium hypochlorite,
1,3-dichloro-5,5-dimethylhydantoin (DCDMH),
1,3-dibromo-5,5-dimethylhydantoin (DBDMH),
1-bromo-3-chloro-5,5-dimethylh- ydantoin (BCDMH),
1,3-dichloro-5-ethyl-5-methylhydantoin (DCEMH),
1,3-dibromo-5-ethyl-5-methylhydantoin (DBEMH),
1-bromo-3-chloro-5-ethyl-5- -methylhydantoin (BCEMH), and mixtures
thereof and one or more of a clarifier, chelating agent,
sequesterant, algaestat, water softener, algaecide, corrosion
inhibitor, scale inhibitor, flocculent, disintegrant, dispersant,
colorant, dissolution control agent, or surfactant.
21. The multilayer tablet according to claim 20 wherein the fast
dissolving layer is formulated to release the combination of active
ingredients in less than 12 hours.
22. The multilayer tablet according to claim 20 wherein the slow
dissolving layer is formulated to release said component in an
extended period of time that is greater than 1 day.
23. The multilayer tablet according to claim 20 wherein the fast
dissolving layer is formulated to release a combination of active
ingredients in less than 2 hours upon addition to a water
system.
24. The multilayer tablet according to claim 20 wherein the slow
dissolving layer is formulated to release the combination of
components in a time period from 2 to 120 days upon addition to the
water system.
25. The multilayer tablet according to claim 20 wherein the fast
dissolving layer is anhydrous sodium dichloroisocyanuric acid and
the slow dissolving layer is trichloroisocyanuric acid.
26. The multilayer tablet according to claim 20 wherein an active
halogen component is present in the slow dissolving layer at a
level of from 50% to 99% by weight.
27. The multilayer tablet according to claim 26 wherein the amount
of active halogen component is present in the slow dissolving layer
at a level of 75% to 95% by weight.
28. The multilayer tablet according to claim 20 wherein the fast
dissolving layer has a dissolution aid selected from the group
consisting of alkali metal and alkaline earth carbonate salts,
sodium cyanurate, disodium cyanurate and trisodium cyanurate.
29. The multilayer tablet according to claim 20 wherein the fast
dissolving layer includes a member selected from the group
consisting of sodium or potassium monopersulfate, sodium persulfate
and potassium persulfate.
30. The multilayer tablet according to claim 20 wherein the tablet
contains a corrosion inhibitor.
31. The multilayer tablet according to claim 20 wherein the tablet
contains a scale inhibitor or water softener.
32. The multilayer tablet according to claim 20 wherein the tablet
contains a water clarifier.
33. The multilayer tablet according to claim 20 wherein the tablet
contains an oxidizer.
34. The multilayer tablet according to claim 20 wherein the tablet
contains an algaecide.
35. The multilayer tablet according to claim 20 wherein the tablet
contains a surfactant and/or dispersant.
36. The multilayer tablet according to claim 20 wherein the tablet
contains a binder.
37. The multilayer tablet according to claim 36 wherein the binder
is a member selected from the group consisting of natural polymers
and synthetic polymers.
38. The multilayer tablet according to claim 37 wherein the tablet
contains a colorant.
39. A method for treating a toilet tank which comprises introducing
into said toilet tank a multifunctional, multilayer tablet, wherein
the multilayer tablet consists of a fast dissolving layer and a
slow dissolving layer, wherein said fast dissolving layer releases
a combination of active ingredients including a member selected
from the group consisting of lithium hypochlorite, calcium
hypochlorite, trichloroisocyanuric acid (TCCA), anhydrous sodium
dichloroisocyanurate, sodium persulfate, potassium persulfate,
potassium monopersulfate, and mixtures thereof, and at least one of
a clarifier, chelating agent, sequesterant, algaestat, water
softener, algaecide, corrosion inhibitor, scale inhibitor,
flocculent, disintegrant, dispersant, colorant, dissolution control
agent, fragrance, or surfactant and, wherein said slow dissolving
layer includes a member selected from the group consisting of
trichloroisocyanuric acid (TCCA), calcium hypochlorite,
1,3-dichloro-5,5-dimethylhydantoin (DCDMH),
1,3-dibromo-5,5-dimethylhydan- toin (DBDMH),
1-bromo-3-chloro-5,5-dimethylhydantoin (BCDMH),
1,3-dichloro-5-ethyl-5-methylhydantoin (DCEMH),
1,3-dibromo-5-ethyl-5-met- hylhydantoin (DBEMH),
1-bromo-3-chloro-5-ethyl-5-methylhydantoin (BCEMH), and mixtures
thereof, and at least one of a clarifier, chelating agent,
sequesterant, algaestat, water softener, algaecide, corrosion
inhibitor, scale inhibitor, flocculent, disintegrant, dispersant,
colorant, dissolution control agent or surfactant.
40. The method according to claim 1 wherein the slow dissolving
layer is formulated to release the combination of components in a
time period between 2 and 150 days upon addition to the water
system.
Description
INTRODUCTION AND BACKGROUND
[0001] The present invention relates to dual layer tablets for the
treatment of water to enhance and improve the properties thereof.
In a further aspect, the present invention relates to the methods
of making the dual layer tablets and the uses thereof.
[0002] In a water system that includes recreational applications
(i.e. pools or spas), industrial water applications (i.e. cooling
towers) or household applications (i.e. bathroom toilets), the
purification of the water and the system containing the water are
usually done by using a wide variety of biocides, sanitizers,
disinfectants, dispersants, or surfactants. All the products are
either in a liquid or solid form.
[0003] One of the challenges for these types of products is that
the tablets must have good tablet strength, good tablet quality and
show no sign of fracture, swelling or breakage under normal storage
conditions. The tablets must also readily dissolve and release the
active ingredients to provide multifunctionality. These products
should be capable of being designed to provide immediate treatment
and slow and long lasting maintenance to the water system.
[0004] Another problem for the treatment of such water systems is
associated with the fact that customers have to use and store many
different chemicals to take care of just one system. An all-in-one
type product is rarely available for consumers to use that would
provide the desired multifunctionality and benefits. In
recreational water treatment applications like swimming pools and
spas, a fast dissolving solid (such as sodium dichloroisocyanuric
acid, lithium hypochlorite or formulations thereof) are used to
provide a dosage of the active oxidizer or sanitizer (i.e. source
of hypochlorous acid) on contact with water. Likewise, the
sanitizer is often a slow dissolving solid (such as
trichloroisocyanuric acid, calcium hypochlorite,
1,3-dichloro-5,5-dimethylhydantoin,
1-bromo-3-chloro-5,5-dimethylhydantoin,
1,3-dichloro-5-ethyl-5-methylhyda- ntoin or formulations thereof)
to maintain a sanitizer residual for an extended period of
time.
[0005] Similarly, algaestats and algaecides, which help prevent the
buildup of algae or fungi, and water clarifiers, which help remove
particles from water are typically added as separate products for
the treatment of recirculating water systems. Similarly, in
industrial water treatment, such as for cooling towers, sanitizers
are specifically designed to kill microorganisms which lead to
biofouling, biofilms and the like, where corrosion and scale
inhibitors are added separately to reduce corrosion and scale in
the system.
[0006] As a result, consumers or operators spend considerable time
and resources to maintain a wide spectrum of chemicals and to
determine when, why, and how much of these chemicals must be added
to their water system. Hence, a product with multifunctionality
would have great value in treating water that requires such
chemical treatment, including toilet bowls, swimming pools, spas
and industrial water applications. In addition, oxidizers or other
chemicals that are added to these systems are often not compatible
when commingled with each other and hence undesirable. In such
instances, the activity of the oxidizer or sanitizer will diminish
over time. Tableting separate layers of oxidizers or sanitizers
overcomes the disadvantages outlined above. Also relevant to this
invention is that different rates of dissolution for oxidizers and
sanitizers as separate layers within a single tablet would be
advantageous. A commingled blend with different oxidizers or
sanitizers would not satisfy this need.
[0007] Multilayer tablets (specifically dual layer), ring/core and
jacket/core tablets have been established in the prior art in the
pharmaceutical and household uses, particularly for automatic
dishwashing applications. The prior art in dual layer tablets has
focused on releasing various active substances at different rates
to ensure that both layers of the tablet are not dissolved
simultaneously or for separating ingredients which are incompatible
with one another.
[0008] Kruse, et al. (U.S. Pat. No. 4,828,749) discloses a dual
layer tablet for dishwashing applications. The said composition is
comprised of one layer of a metal silicate, metal triphosphate and
surfactant while the second layer is comprised of a metal silicate,
metal triphosphate and from 0.5 to 5% of an active halogen
releasing compound such as trichloroisocyanuric acid (TCCA) or
sodium dichloroisocyanuric acid (NaDCCA).
[0009] Chun, et al. (U.S. Pat. No. 5,133,892) discloses a
multilayer tablet which separates a source of halogen bleach (from
0.1% to 20% by weight available chlorine) from a combination of a
peroxygen bleach and an enzyme by means of a barrier.
[0010] Wschenbach, et al. (U.S. Pat. No. 6,194,368) also discloses
a dual layer tablet for dishwashing applications where an oxygen or
chlorine containing bleach (present between 1% and 40% by weight)
and a corrosion inhibitor is separated from a bleach activator.
[0011] Saslawski, et al. (U.S. Pat. No. 6,372,255) discloses a much
broader application of multi-layered tablet technology relating to
the instant and then prolonged release of active substances
comprising of at least two superposed layers. However, the second
layer of the tablet comprises a nonbiodegradable inert porous
polymeric material in which the active material is dispersed.
[0012] The only prior art that applicants have uncovered which
mentions the use of a contiguous dual layer tablet for treating
recirculating water is disclosed by Kibbel and Hollenbach in U.S.
Pat. No. 3,873,685. Kibbel, et al. discloses a process for
producing a contiguous, layered tablet consisting of a fast
dissolving layer of sodium dichloroisocyanuric acid dihydrate
(NaDCCA.2H.sub.2O), and a slow dissolving layer of
trichloroisocyanuric acid (TCCA).
[0013] Karbowski, et al. (U.S. Pat. No. 4,800,082) discloses a
sustained release microbiological control composition in the form
of tablets for aqueous industrial systems.
[0014] Lavatory cleaning blocks which release a halogen
disinfecting agent in a controlled, substantially constant rate as
shown in Hung, et al. (U.S. Pat. No. 5,178,787).
[0015] Farina, et al. (U.S. Pat. No. 5,603,941) discloses a
compacted or tableted composition containing at least one
biodispersant, at least one halogenated biocide and a halogen
scavenger.
[0016] Secemski (U.S. Pat. No. 5,783,540) discloses tablets having
at least two layers for dishwashing applications.
[0017] Another multilayered dishwashing tablet is shown by Gorlin,
et al. (U.S. Pat. No. 5,962,387).
[0018] Detergent shaped bodies are described by Holderbaum, et al.
(U.S. Pat. No. 6,251,848) wherein active substances are represented
from one another as a core/jacket shaped body.
SUMMARY OF THE INVENTION
[0019] Therefore, it is a purpose of the present invention to
provide a product which combines several treatments in a single
multi-layer tablet application which would be very advantageous.
For example, in one embodiment, the composition would first
introduce a fast dissolving product composition (such as a shock
level of oxidizer or sanitizer, corrosion inhibitor,
scale-inhibitor, clarifier, surfactant, algaestat, algaecide and
the like) for the pretreatment of a body of water such as pool,
spa, cooling tower, or toilet. Secondly, such product would also
deliver a slow-dissolving sanitizer composition, which would
dissolve in the body of water over a prolonged period of time, such
as several days. Thus, efficacious dosages of several different
components could be delivered in a single multi-layer tablet
application, providing ease of use and multifunctionality for
treating water for lavatories, swimming pools, spas and industrial
water applications such as cooling towers. The tablets of this
invention can have more than two layers according to the end
purpose to be achieved.
[0020] Another purpose of the present invention is to provide just
one product for a comprehensive treatment regiment for a water
system, which is now only accomplished by the use and addition of
different chemicals at different times. Thus, consumers will be
able to achieve greater convenience from the present invention.
[0021] The above and other purposes of the present invention can be
achieved by the multi-layer tablet systems as described herein
which provide both multifunctional treatments and maintenance to a
recirculating water system such as pool, spa, or cooling tower, or
in a non-recirculating water system such as a toilet. The products
prepared according to this invention are simple in form and
application but comprehensive in functionality. The products will
not only provide both instant and/or long lasting treatment to a
water system, but also offer comprehensive treatment to the water
system through the addition of multiple function components.
[0022] A dual layer system according to one aspect of the present
invention consists of a fast dissolving layer (FDL) which releases
an oxidizer or sanitizer and one or more active ingredients such as
a clarifier, chealant, sequesterant, algaestat, water softener,
algaecide, corrosion inhibitor, scale inhibitor, flocculent,
disintegrant, dispersant, colorant, dissolution control agent,
fragrance or surfactant and the like in a short period of time;
that is, in less than 12 hours, more preferably in less than 2
hours upon addition to the water system. The slow dissolving layer
(SDL) of the dual layer system is formulated to release a
combination of biocide, sanitizer, oxidizer, clarifier, chealant,
sequesterant, algaestat, water softener, algaecide, corrosion
inhibitor, scale inhibitor, flocculent, disintegrant, dispersant,
colorant, dissolution control agent or surfactant and the like over
an extended period of time; that is greater than 1 day, more
preferably between 2 and 150 days depending on which application
the product is intended.
[0023] The method of the present invention involves treating a
recirculating water system which comprises introducing into said
water system a multifunctional, multilayer tablet, wherein the
multilayer tablet includes a fast dissolving layer and a slow
dissolving layer wherein said fast dissolving layer releases a
combination of active ingredients including a member selected from
the group consisting of anhydrous sodium dichloroisocyanuric acid,
lithium hypochlorite, calcium hypochlorite and mixtures thereof,
and at least one of a biocide, clarifier, chelating agent,
sequesterant, algaestat, water softener, algaecide, corrosion
inhibitor, scale inhibitor, flocculent, disintegrant, dispersant,
colorant, dissolution control agent, fragrance, or surfactant, and
wherein said slow dissolving layer includes a member selected from
the group consisting of trichloroisocyanuric acid (TCCA), calcium
hypochlorite 1,3-dichloro-5,5-dimethylhydantoin (DCDMH),
1-bromo-3-chloro-5,5-dimethylhydantoin (BCDMH),
1,3-dichloro-5-ethyl-5-me- thylhydantoin (DCEMH) and mixtures
thereof, and at least one of a biocide, clarifier, chelating agent,
sequesterant, algaestat, water softener, algaecide, corrosion
inhibitor, scale inhibitor, flocculent, disintegrant, dispersant,
colorant, dissolution control agent or surfactant.
DETAILED DESCRIPTION OF INVENTION
[0024] According to the state of the art, the use of a contiguous
dual layer tablet for treating recirculating water is known as
shown by Kibbel and Hollenbach in U.S. Pat. No. 3,873,685. The
product disclosed by Kibbel, et al. is a contiguous, layered tablet
consisting of a fast dissolving layer of sodium dichloroisocyanuric
acid dihydrate (NaDCCA.2H.sub.2O), and a slow dissolving layer of
trichloroisocyanuric acid (TCCA). The present invention is
characterized by some important and notable differences with
respect to U.S. Pat. No. 3,873,685.
[0025] It is disclosed in U.S. Pat. No. 3,873,685, that sodium
dichloroisocyanuric acid dihydrate (NaDCCA.2H.sub.2O) and not
anhydrous sodium dichloroisocyanuric acid (NaDCCA) was suitable as
the active component in the fast dissolving layer (FDL) of the
tablet. Kibbel et al. points out the following:
[0026] First, that the contiguous dual layered tablets containing
NaDCCA were formed only with difficulty under high pressures
(around 60,000 p.s.i.). The patentees also disclose that under
these high pressures, some of the NaDCCA decomposed causing a
decrease of available chlorine in the product. According to the
patent, NaDCCA does not tablet easily at conventional pressures of
about 15,000 to 25,000 p.s.i.
[0027] Secondly, the patentees disclosed that even when the
contiguous dual layered tablets were formed with NaDCCA, the
tablets themselves were not "dimensionally stable." This term
reflects the fact that the tablets were reported to swell and
develop weak structures upon prolonged exposure to small amounts of
moisture, thus making the dual layer tablet structure unstable.
[0028] Furthermore, the patentees specifically state that
compositions with NaDCCA were successfully tableted only when a
lubricant such as boric acid or stabilizers such as boron oxide and
sodium carbonate were employed.
[0029] One of the other limitations of the prior art disclosed in
U.S. Pat. No. 3,873,685 is that the tablet consists solely of a
layer of NaDCCA.2H.sub.2O and a layer of TCCA. Hence, the prior art
does not disclose the ability of the tablets to provide
multifunctionality as is provided for by the present invention.
U.S. Pat. No. 3,873,685 only teaches that conventional additives
such as various dyes, perfumes and the like can be added to either
component of the contiguous tablet structure.
[0030] Applicants have proceeded clearly contradictory to what was
taught in U.S. Pat. No. 3,873,685. First and foremost is that a
contiguous dual layer tablet can indeed be produced by using
anhydrous sodium dichloroisocyanuric acid (NaDCCA) in combination
with TCCA at a variety of pressures (see Table 1). In addition, it
has been found that the dual layer tablets formed using NaDCCA and
TCCA offered good tablet strength, good tablet quality and did not
show signs of fracture, swelling or breakage upon storage at room
temperature for 4 months. When tested under high humidity and
elevated temperature (50.degree. C.) only those tablets prepared at
high pressures (25,000 p.s.i.) exhibited small cracks between the
two layers. However, in none of the examples was separation of the
layers evident. To further substantiate applicants' observations,
dual layer tablets containing anhydrous NaDCCA and TCCA in separate
layers were prepared with the same dimensions, weights and tablet
pressures as described in U.S. Pat. No. 3,873,685 with TCCA and
NaDCCA.2H.sub.2O and the results are presented in Table 1.
1TABLE 1 Preparation of contiguous dual layer tablets using
trichloroisocyanuric acid (TCCA) and anhydrous sodium
dichloroisocyanuric acid (NaDCCA). 1st layer 2nd layer Tableting
TCCA NaDCCA pressure Tablet Crush (grams) (grams) (psi) height (cm)
strength (lbs.) 3 6 10,000 1.09 45 4 8 1.46 68 5 10 1.82 72 6 12
2.17 116 3 6 15,000 1.05 66 4 8 1.40 103 5 10 1.75 77 6 12 2.09 133
3 6 20,000 1.01 100 4 8 1.36 137 5 10 170 127 6 12 2.05 187 3 6
25,000 1.00 125 4 8 1.34 146 5 10 1.67 185 6 12 1.99 218 4.5 4.5
10,000 1.06 35 6 6 1.42 54 7.5 7.5 1.77 69 9 9 2.13 74 4.5 4.5
15,000 1.02 46 6 6 1.35 88 7.5 7.5 1.69 115 9 9 2.03 121 4.5 4.5
20,000 0.98 62 6 6 1.31 110 7.5 7.5 1.64 134 9 9 1.97 150 4.5 4.5
25,000 0.98 94 6 6 1.29 127 7.5 7.5 1.62 160 9 9 1.93 212
[0031] Tablets were pressed on a Carver hydraulic press. Tablet
heights were measured immediately after pressing. Tablet crush
strengths were measured two hours after tablet was prepared.
[0032] It is clearly shown from Table 1 above that none of the
above tablets were difficult to prepare as is reported in U.S. Pat.
No. 3,873,685. In addition, no tablet aid was used in making these
tablets. Thus, no lubricant is required according to the present
invention.
[0033] Each tablet was also visually inspected and no cracks were
found on any of these tablets. Almost each tablet has a smooth and
shining surface. The two layers in the same tablet were almost
indistinguishable, especially at higher pressures.
[0034] The other aspect of the present invention, that U.S. Pat.
No. 3,873,685 does not teach, is the ability to use multifunctional
components in either one of the layers, nor does it disclose the
use of other biocidal compounds for treating water. U.S. Pat. No.
5,603,941 teaches the use of a composition including halogenated
hydantoins such as 1,3-dichloro-5,5-dimethylhydantoin (DCDMH) and
1-bromo-3-chloro-5,5-dimet- hylhydantoin (BCDMH) and
biodispersants. These patents are obviously limited in that they do
not provide the ability to quickly treat the water using these
biocides once the tablet is placed in the recirculating water
system.
[0035] In household applications, such as toilet cleaning
applications, the patent literature contains many examples of
single layered formulated compositions as can be seen in U.S. Pat.
Nos. 4,820,449, 4,911,858, 5,178,787, 5,603,941, 5,763,376,
6,001,783, 6,103,681, 6,124,251. However, none of this prior art
focuses on a contiguous dual layer/dual function tablet for such
applications.
[0036] Therefore, a feature of the present invention resides in the
multifunctionality provided by the contiguous dual layer tablet for
water treatment, particularly pools, spas, cooling towers and the
like. The present invention also has applicability in toilet
cleaning operations. Thus, one aspect of the present invention
relates to treating water through the use of a single, contiguous
tablet which contains both a fast dissolving layer (FDL) containing
a formulated active halogen releasing compound and a slow
dissolving layer (SDL) containing a formulated halogen releasing
compound. These formulations within the FDL and SDL incorporate a
clarifier, chealant, sequesterant, algaestat, water softener,
algaecide, corrosion inhibitor, scale inhibitor, flocculent,
disintegrant, dispersant, colorant, dissolution control agent, or
surfactants as auxiliary components. The multifunctional system
thus provides both an instant treatment and a longer lasting
sustained treatment capability. This invention is also unique in
the fact that many optional functional components can be
incorporated into a single contiguous tablet without compromising
the tablet quality and long term storage stability.
[0037] Slow Halogen Dissolving Compounds:
[0038] The preferred major active component in the SDL is a mixture
containing primarily an agent which slowly dissolves and releases a
halogen disinfectant agent when in contact with water, primarily
bromine and chlorine donor biocides. A specific example is TCCA.
Others include halogenated hydantoins such as
1-bromo-3-chloro-5,5-dimethylhydantoin (BCDMH),
1,3-dichloro-5,5-dimethylhydantion (DCDMH),
1,3-dichloro-5-ethyl-5-methylhydantoin, or combinations thereof.
Other N-halogenated compounds include N,N,N-trichloromelamine, or
N,N,N,N-tetrachloroglycoluril. The preferred halogen releasing
compounds for the embodiment of this invention is TCCA and BCDMH,
most preferably TCCA. The active halogen component is generally
present in SDL at a level of from 50% to 99% and more preferably
from 75% to 95% by weight of the SDL.
[0039] Slow halogen dissolving compounds could also be used as the
active halogen component of the FDL when they are formulated with
dissolution aids such as alkali metal and alkaline earth metal
carbonate salts to increase the speed of dissolution, including
sodium carbonate, sodium bicarbonate, potassium carbonate and
calcium carbonate. Other examples of dissolution aids include the
alkali metal salts of cyanuric acid such as sodium cyanurate,
disodium cyanurate and trisodium cyanurate. Also included are
silicates such as sodium metasilicate. Slow halogen dissolving
compounds could also be formulated with peroxygen compounds such as
sodium or potassium monopersulfate or sodium or potassium
persulfate in the FDL.
[0040] The active halogen component of the SDL can also be
formulated with dissolution aids to decrease the rate of
dissolution as described, but not limited to those as described in
U.S. Pat. No. 5,478,482 which includes unsubstituted and
substituted glycolurils.
[0041] Fast Halogen Dissolving Compounds:
[0042] The preferred major active component in the FDL is a mixture
containing primarily an agent which dissolves fast and releases a
halogen disinfectant agent when in contact with water, primarily
bromine and chlorine donor biocides. Specific examples include
alkali metal salts of dihalo cyanurates such as anhydrous sodium
dichloroisocyanuric acid (NaDCCA), and mixtures thereof. Other
biocides can include alkali metal and alkaline earth metal
hypochlorites such as lithium hypochlorite and calcium
hypochlorite. The most preferred halogen releasing compounds for
the embodiment of this invention is NaDCCA. The active halogen
component is generally present in FDL at a level of from 10% to
85%, more preferably from 30% to 75% by weight of the FDL.
[0043] Due to the highly reactive nature of calcium hypochlorite
and lithium hypochlorite, an encapsulating technique familiar to
those skillful in the art can be employed to coat the calcium
hypochlorite or lithium hypochlorite particles with a layer of fast
dissolving compounds such as silicates, sulfates, phosphates, or
chlorides before incorporating the oxidizers in the FDL.
[0044] It is also possible to use a blend of different fast halogen
releasing compounds instead of composing the FDL with an individual
halogen-releasing compound.
[0045] Corrosion Inhibitors:
[0046] Corrosion inhibitor components can be incorporated into
either SDL or FDL depending on the solubility and application.
However it is preferred to add at least the majority of corrosion
inhibitors in FDL. Suitable corrosion inhibitors include zinc
sulfate, zinc oxide, sodium molybdate dihydrate, sodium
hexametaphosphate, sodium tripolyphosphate, sodium phosphate,
sodium nitrates, silicates, or their mixtures. Among them zinc
oxide has very limited solubility and is preferred to be used in
SDL composition. The corrosion inhibitor can be present in FDL in
an amount of from 0 to 20%, more preferably from 0 to 15%, most
preferably from 0 to 10% by the weight of FDL.
[0047] If non-oxidizer based SDL is used, in addition to the
corrosion inhibitors mentioned above, those corrosion inhibitors or
their mixtures which are not compatible with halogen-releasing
compounds could be used. The examples include
mercaptobenzothiazole, benzotriazole, tolyltriazole,
aminotrimethylenephosphonic acid,
1-hydroxyethylidene-1,1-diphosphonic acid (HEDP),
phosphonohydroxyacetic acid, or phosphonobutane tricarboxylic acid
(PBTC).
[0048] Scale Inhibitors/Water Softener:
[0049] These products can be used in either SDL or FDL depending on
the objective of the application and scale inhibitor or water
softener's solubility. The scale inhibitor or water softener may be
any suitable compound or mixture compatible with other components
in the system. In the case that halogen releasing or strong
oxidizing compounds are used in the dual layer tablet, suitable
scale inhibitors or water softeners or their mixtures are, for
example, sodium hexametaphosphate, trisodium phosphate, sodium
tripolyphosphate, and may include polymers such as polyacrylates,
polymethacrylates, polymaleic acid, acrylic acid copolymers,
acrylic acid-sulfonic acid coploymers, phosponocarboxylic acid
polymers, phosphinocarboxylic acid polymers, polyisobutylene maleic
anhydride copolymers, or polysodium sulfonate styrene maleic
anhydride copolymers, or salts thereof.
[0050] These scale inhibitor/water softeners are normally included
in the FDL in an amount from 0 to 20% by the weight of FDL,
preferably from 1 to 15% and more preferably from 2 to 10% by the
weight of FDL, or in the SDL in an amount form 0 to 10% by the
weight of SDL, preferably from 0 to 5% by the weight of SDL.
[0051] If no strong oxidizer or halogen releasing compounds are
used in either of the two layers, then in addition to the scale
inhibitors or water softeners used above, other corrosion
inhibitors/water softeners can also be used. They are, for example,
amine phosphates, aminotrimethylenephosphonic acid,
1-hydroxyethylidene-1,1-diphosphonic acid, gluconic acid, citric
acid, ethylenediaminetetraacetic acid or salt (EDTA),
phosphonohydroxyacetic acid, phosphonobutane tricarboxylic acid
(PBTC), nitrilotriacetic acid or salts thereof.
[0052] In case that scale inhibitors or water softeners are in
liquid form, a dry blend of the liquid scale inhibitors or water
softeners with other dry and porous components which can combine
water have to be obtained through agglomeration prior to tableting.
This requirement applies to any situation where a liquid component
is involved for the invention. A specific formulation has to be
designed to allow the liquid compound to be adsorbed and tightly
incorporated into the system.
[0053] Water Clarifiers:
[0054] Suitable water clarifiers for this invention are, for
example, aluminum sulfate, potassium alum, ammonium alum, ferrous
sulfate, ferric sulfate, ferric chloride, polyacrylamide,
N,N-dialkyl methylbenzylammonium chloride, polydimethyl-diacrylic
acid chloride, or polyacrylate/acrylamide copolymer or their
mixtures. N,N-dialkyl methylbenzylammonium chloride could also be
used as a biocide in the system.
[0055] The water clarifiers can be present in FDL in an amount from
0% to 25% by weight and preferably from 2 to 15% by weight of the
total weight of FDL. Clarifiers can also be present in the SDL in
an amount from 0% to 15%, preferably from 2 to 10% by weight of the
SDL.
[0056] Oxidizers:
[0057] Oxidizers are preferred to be included in FDL for the fast
release and into the water system. They include, for example,
sodium or potassium monopersulfate, sodium or potassium
persulfate.
[0058] For the embodiment of this invention, the oxidizer is
present in the FDL of an amount of 2% to 50%, preferably from 10%
to 40%, by weight of FDL.
[0059] Biocides and Algaecides:
[0060] Dependent on different applications, either SDL or FDL may
comprise non-oxidizing biocides, algaecides, or sanitizers as the
major active ingredients for a specific water system especially
when halogen is not appropriate for the system.
[0061] Suitable biocides or algaecides for the embodiment of this
invention are, for example, sodium tetraborate, potassium
tetraborate, copper salts, silver salts, zinc salts, glutaradehyde,
alkyl isothiazolin-3-ones, bis (trichloromethyl) sulfone, bis
(tributyltin) oxide,
2-(tert-butylamino)-4-chloro-6-(ethylamino)-s-triazine,
tetrachloro-2,4,6-cyano-3-benzonitrile, 2-(thiocyanomethylthio)
benzothiazole, 2-bromo-4-hydroxyacetophenone,
2-bromo-2-nitropropane-1,3-- diol, sodium dimethyldithiocarbamate,
2,2-dihydroxy-5,5-dichlorodiphenyl monosulfide,
2-2-dibromo-3-nitrilopropionamide, 2-(decylthio) ethanamine,
methylene bis (thiocyanate),
poly[oxyethylene(dimethyliminio)]ethylene dichloride,
alkyldimethylbenzylammonium chloride, N,N-dialkyl
methylbenzylammonium chloride,
tetrahydro-3,5,dimethyl-2H-1,3,5-thiadiazi- ne-2-thione, tetrakis
(hydroxymethyl) phosphonium sulfate, or
tributyltetradecylphosphonium chloride.
[0062] These biocides or algaecides are used as secondary biocides
or algaecides in the FDL layer in case that halogen releasing
compounds are used as primary biocides in both layers. However,
they could be used as primary biocides or algaecides in both
layers. If the non-oxidizer based biocides or algaecides are used
as the primary biocides in SDL and have high solubility or poor
tableting quality, then a hydrophilic polymer may be used as taught
from the previous state of the art as illustrated by U.S. Pat. No.
4,800,082.
[0063] When these biocides or algaecides are used with other
halogen releasing agents or strong oxidizers, caution has to be
taken to ensure the compatibility between the selected biocides or
algaecides and halogen releasing agents or strong oxidizers.
[0064] As a primary biocide or algaecide, they can be present in
the FDL of the invention in an amount from 0% to 30%, and
preferably from 0.5% to 15% by weight of the FDL. In the case of
the SDL, the biocide/algaecide can be present from 0% to 60%, more
preferably from 5% to 45% by weight of the SDL. As a secondary
biocide or algaecide, they can be present in the FDL of the
invention in an amount from 0% to 20%, and preferably from 0.5% to
10% by weight of the FDL. In the case of the SDL, the biocide or
algaecide is present from 0% to 30%, more preferably from 0.5% to
15% by weight of the SDL.
[0065] Surfactants and Dispersants:
[0066] Surfactants and dispersants can be placed in either of the
two layers dependent of specific application objectives and
stability considerations. For example, a thin layer of FDL can be
combined with a thick layer of bleaching SDL to construct a dual
layer toilet tablet. Once the tablet is placed in a toilet tank,
the surfactants in the FDL will be released immediately to clean
the toilet bowl and reduce manual cleaning as is required by most
of the previous state of the art.
[0067] Suitable surfactants include, for example, nonionic
surfactants such as ethylene oxide or propylene oxide copolymers,
alkylene oxide condensates of fatty acids (or their corresponding
sulfates or sulfonates), fatty alcohols, and alkyl substituted
phenols; amphoteric surfactants such as glycinates or imidazoline
based amphoacetates and propionate, betaine based carboxyl betaines
and sulfo betaines; anionic surfactants such as polyethylene-sodium
polyacrylate copolymers, sodium lauryl sulfate, sodium lauryl
sulfoacetate, sodium dioctyl sulfosuccinate, sodium stearate,
calcium stearate, magnesium stearate, sodium lauryl ether sulfate,
dodecyl benzene sulfonic acid (or the corresponding sulfonate),
.alpha.-olefin sodium sulfonate, sodium 2-ethylhexyl sulfate, alkyl
napthalene sodium sulfonates, linear alkyaryl sodium sulfonates,
secondary alkane sulfonates, and secondary alkene sulfonates.
[0068] The surfactants can be present either in FDL or SDL in
amount from 0.1 to 90%, preferably from 0.1 to 30% and mostly
preferred from 0.5 to 10% by the weight of either the FDL or
SDL.
[0069] Other Components:
[0070] Alternatively, the dual layer tablet can comprise other
customary additives such as binders to hold the different
components in the system together, disintegrants to hold the
composition together when dry and break the tablet quickly once
being exposed to water, tableting aids to ease the tableting
process, colorants to differentiate the two layers and make the
tablet aesthetically appealing, fragrances, and so on.
[0071] The tablet binders and disintegrants include various
polymers such as natural polymers and synthetic polymers. These
include, for examples, various natural starches and starch
derivatives, cellulose and cellulose derivatives, gums and gum
derivatives, polyvinylpyrrolidones, polymethacrylates,
polyacrylates, polyethylene glycols, or polyvinyl alcohols. Some
inorganic materials can also be used as tablet binders and
disintegrants. They are, for example, various salts such as
sulfates, chlorides, borax, silicates, various clays such as
bentonite and montmorillonite. Precaution should be practiced when
choosing binders to ensure the compatibility between the binders
and other components in the system.
[0072] Generally, tableting aids are included in the composition to
ease the injection of the tablet out of the die after compression.
The examples of tableting aids are boric acid and sodium stearate.
The tableting aid can either be incorporated into the tablet
composition beforehand or sprinkled directly onto the cylindrical
metal surface through which the tablet was compressed and ejected
during tableting operation.
[0073] Any colorants can be used to blend into the tablet
composition if no strong oxidizer or halogen-releasing agents are
part of the system. In case the strong oxidizing or
halogen-releasing agents are used, stable colorants have to be
considered for the composition. They include but not limited to,
for example, FD&C blue 1, FD&C green 3, C.I. 74120, 74300,
and 74320, C.I. acid blue 249, C.I. direct blues 86 and 87, C.I.
ingrain blues 1, 2, 3, and 5, C.I. pigment blues 15:1, 15:2, 15:3,
and 17, C.I. pigment greens 7 and 37, and C.I. solvent blues 24,
25, and 55, C.I. vat blue 6 and 11, C.I. vat blue 42, and 47, C.I.
acid yellow 23.
[0074] Tablet Structure:
[0075] The dual layer tablet for the embodiment of this invention
can take any geometric shape dependent on specific applications and
consumer preference.
[0076] The shape of the interface between the two layers of the
dual layer tablet can also be flexible. It can be a clear-cut flat
surface or three-dimensional irregular interface. Again the design
of the two-layer interface is dependent on the specific application
and individual's preference.
[0077] The weight ratio between SDL and FDL is also designed based
on the objective of the particular application without limitation.
Similarly, the total weight and size of the dual layer tablet are
determined by the specific application. The total weight of the
dual layer tablet can vary widely depending on its ultimate use and
the environment in which it is to be placed. Typical weights range
from 5 to 2000 grams.
[0078] Furthermore, the ratio between the width and height for the
dual layer tablet is selected based on the desired performance of
the tablet and the difficulty level of manufacturing.
[0079] Particle Size:
[0080] It is unexpectedly found from this invention that the
particle size of raw materials forming both FDL and SDL is
important in determining the tablet strength and shelf stability of
the dual layer tablet, especially when granular particles are used
as the major components for both layers (see Table 2). Therefore
they have to be selected based on careful considerations.
[0081] The tablet strength is referred to in this invention as the
amount of force needed to crush the dual layer tablet when the
tablet is standing on its side and subject to a force on a crush
strength testing instrument. The tablet shelf stability is related
to the time needed to split the two layers of the tablet due to the
different swelling behaviors for the two layers under normal
storage conditions. Good tablet strength does not necessarily
transfer to good tablet shelf stability.
[0082] The effect of the composition granulation size of both TCCA
and NaDCCA on the dual layer tablet strength was investigated by
testing the crush strength of the tablets as shown in Tablet 2.
2TABLE 2 Crush Strength of Dual Layer Tablets Prepared with
Different Granulation Sizes of TCCA and NaDCCA. Top layer
composition and average granulation size NaDCCA FDL composition in
(0.48 mm) Example 1 (0.40 mm) Bottom layer TCCA (3.50 mm) 132 lbs.
79 lbs. composition TCCA (1.60 mm) 176 lbs. 75 lbs. and average
TCCA (0.59 mm) 184 lbs. 122 lbs. granulation size TCCA (0.49 mm)
179 lbs. 130 lbs.
[0083] The result indicated that the identical or close particle
size for both layer compositions will help to improve the dual
layer tablet crush strength especially when one of the layers has
poor tableting quality. Therefore the suitable average granular
particle size for both the SDL and the FDL layer components are
preferably equivalent.
[0084] It is also found from this invention that using binders in
both layers will improve the adhering strength between the two
layers and therefore extend the dual layer tablet shelf
stability.
[0085] Tablet Compression:
[0086] Any type of press can be used for practicing this invention
as long as the feeding system is appropriately designed to allow
the feeding of two layer materials into the compressing zone at
different intervals. All the examples illustrated by this invention
were produced using a lab-scale Carver press.
[0087] The process is relatively simple. The first layer material
was first fed into the die compartment. The die was then shaken to
level off the first layer material in the die compartment. The
second layer material was then fed into the die and placed on the
top of first layer material. After the pressure was applied on the
material in the die compartment, the tablet was formed using
varying pressures and ejected using the same press.
EXAMPLES
[0088] Examples of the contiguous dual layer tablets are listed in
Table 3, all consisting of an FDL and a SDL. The tablets with the
following compositions in both layers are made using a Carver press
and 2 inch (50.8mm) diameter die. A force of 22,000 pounds (9979
kg) is applied on all the tablets with zero dwell time for the
purpose of illustration.
[0089] For all the tablets, the layer with mixture compositions was
first mixed until homogeneous. The first layer of the materials
were then fed into the die cavity followed by shaking the die to
level off the top surface of already fed material in the die
cavity. The second layer of the material was then placed on the top
of the first layer in the cavity and followed by placing the
plunger on top of the second layer. The die unit was then placed on
the platform of the Carver press which was programmed with the
appropriate parameters for compression force and dwell time.
[0090] Examples 1 through 5 were designed for recreational water
applications. They are all composed of a FDL and a SDL. Examples 1,
2, 3 and 5 contain NaDCCA within the FDL as the major biocide or
algaecide for rapid chlorine release to the circulation water
system. TCCA is the main biocide or algaecide in SDL for these
examples to provide long term release of chlorine to the treated
body of water.
[0091] Example 4 uses TCCA as the key biocide in FDL to release
chlorine to the water system quickly in combination with sodium
carbonate in the same composition. Example 6 is formulated for
industrial water treatment using a combination of TCCA and BCDMH as
the main biocide in the SDL and DCCA as the fast releasing biocide
in the FDL. Example 7 is intended for use as toilet cleaning tablet
where the FDL comprises a fast dissolving composition to deliver a
quick wash to the toilet bowl after applying the tablet to the
toilet tank. The SDL uses a TCCA based composition for the
sanitizer.
3TABLE 3 Specific examples of dual layer tablets using formulated
FDL and SDL layers. Example 1 Example 2 Example 3 Example 4 Example
5 Example 6 Example 7 SDL (layer weight) 40 g 40 g 40 g 40 g 40 g
40 g 50 g TCCA 97.0% 99.0% 95.0% 80.0% 95.0% 60.0% 65.5% BCDMH
35.0% Glycoluril 3.0% 4.5% Sodium chloride 1.0%
5,5-dimethylhydantoin 30.0% Sodium hexametaphosphate 5.0% Zinc
polyphosphate 5.0% Sodium tetraborate 10.0% Aluminium sulfate 10.0%
5.0% FDL (layer weight) 40 g 40 g 40 g 40 g 40 g 20 g 10 g TCCA
50.0% Zinc sulfate 25.0% 25.0% Sodium hexametaphosphate 3.0%
Polyacrylates (Sperse 602ND) 25.0% 5.0% Sodium chloride 40.0%
Sodium bisulfate 25.0% Citric acid 20.0% Sulfo betaine 30.0% NaDCCA
anhydrous 80.0% 97.0% 85.0% 99.0% 5.0% Aluminium sulfate 9.5% 20.0%
Sodium persulfate 9.0% Sodium tetraborate 9.5% 5.0% Copper citrate
1.0% Copper sulfate pentahydrate 1.0% EDTA copper salt 1.0% Sodium
carbonate 10.0% 20.0%
[0092] The tablets in the above examples were evaluated for their
shelf stability at room temperature and elevated temperature and
humidity. Examples 1-7 were placed at room temperature for 7 months
with no signs of splitting, cracking, or segregation along the
interface of the two layers. Examples 1-7 were also placed in an
oven at 50.degree. C. and high humidity for several days with no
signs of splitting, cracking, or segregation along the interface of
the two layers. The two layers for all the tablets are uniformly
integrated.
[0093] Further variations and modifications will be apparent to
those skilled in the art from the foregoing and are intended to be
encompassed herein.
* * * * *